Related Experiment Video

Updated: Aug 18, 2025

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.4K

Chimeric Antigen Receptor T Cells: Toxicity and Management Considerations

Kent A Owusu1, Molly Schiffer2, Sarah Perreault3

  • 1Kent A. Owusu is Care Signature Program Manager and Critical Care Pharmacist, Yale New Haven Health, 20 York Street, New Haven, CT 06510 (Kent.Owusu@ynhh.org).

AACN Advanced Critical Care
|December 8, 2022
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

2.7K
Droplet-based Cytotoxicity Assay to Assess Chimeric Antigen Receptor T cells at the Single-cell Level08:09

Droplet-based Cytotoxicity Assay to Assess Chimeric Antigen Receptor T cells at the Single-cell Level

Published on: March 14, 2025

1.0K

Related Concept Videos